ReviewChemistry (Weinheim an der Bergstrasse, Germany)2026
Strain Release of 1-Azabicyclo[1.1.0]butanes as a Gateway to Highly Functionalized Azetidines: New Strategies and Structural Motifs.
Review in Chemistry (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Over the past decade, the interest of synthetic and medicinal chemists in the azetidine ring has continuously risen, given its impact on (positive) modulation of various physicochemical properties. In fact, the exploration of new azetidine-based monocyclic, spirocyclic, and bridged scaffolds has led to the discovery of new potential 3D bioisosteres for 2D or nonstrained 3D rings frequently employed in drug discovery programs. A popular and recently revived strategy en route to azetidines relies on the use of 1-azabicyclo[1.1.0]butanes as precursors, leveraging the inherent reactivity of the "spring-loaded" transannular bond, connecting the bridgehead carbon to the nitrogen. This review provides an overview of synthetic advances since 2021, emphasizing newly accessed structural motifs, patterns in activation tactics, and use of enabling technologies such as photocatalysis and flow chemistry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.